Table 2.
Univariate analysis for outcomes in case–control comparisons
| Placental allograft (n = 143) | Autologous flap/FTSG (n = 143) | p | |
|---|---|---|---|
| Size of MMS defect, cm2 | 3.5 (3.7) | 3.3 (3.1) | 0.531 |
| Stages for tumor clearance | 2.0 (1.2) | 2.1 (1.1) | 0.605 |
| Experienced no complications | 140.0 (97.9) | 102.0 (71.3) | <0.0001 |
| Postoperative sequelae | |||
| Infection | 3.0 (2.0) | 15.0 (10.0) | 0.004 |
| Bleeding or hematoma | 0.0 (0.0) | 7.0 (5.0) | 0.015 |
| Wound dehiscence | 0.0 (0.0) | 4.0 (3.0) | 0.122 |
| Surgical reintervention | 0.0 (0.0) | 11.0 (8.0) | 0.0007 |
| Nonhealing wound | 0.0 (0.0) | 5.0 (3.5) | 0.060 |
| Poor scar cosmesis | 0.0 (0.0) | 21.0 (15.0) | <0.0001 |
| Scar revision | 0.0 (0.0) | 14.0 (9.8) | <0.0001 |
| Follow-up visits | 3.4 (1.6) | 2.5 (1.1) | <0.0001 |
| Time to discharge, days | 30.7 (16.9) | 30.3 (22.9) | 0.840 |
| Cost of reconstruction, dollars | 4463 (2272) | 3904 (951) | 0.007 |
Data are expressed as absolute number (n) and percent (%) or mean and standard deviation (SD); statistical significance at p < 0.05.